Home/Filings/4/0001062993-23-022328
4//SEC Filing

Dalvey David 4

Accession 0001062993-23-022328

CIK 0001603454other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 4:19 PM ET

Size

15.7 KB

Accession

0001062993-23-022328

Insider Transaction Report

Form 4
Period: 2023-12-07
Dalvey David
Director
Transactions
  • Sale

    Common Stock

    2023-12-08$15.00/sh5,000$75,000240,000 total(indirect: By Brightstone Venture Capital Fund, LP)
  • Sale

    Common Stock

    2023-12-07$14.85/sh5,000$74,250245,000 total(indirect: By Brightstone Venture Capital Fund, LP)
Holdings
  • Stock Option (right to buy)

    Exercise: $9.58Exp: 2033-05-15Common Stock (11,645 underlying)
    11,645
  • Common Stock

    9,325
  • Stock Option (right to buy)

    Exercise: $5.50Exp: 2029-05-16Common Stock (5,054 underlying)
    5,054
  • Stock Option (right to buy)

    Exercise: $5.50Exp: 2031-05-12Common Stock (2,310 underlying)
    2,310
  • Stock Option (right to buy)

    Exercise: $5.50Exp: 2032-05-17Common Stock (24,449 underlying)
    24,449
  • Stock Option (right to buy)

    Exercise: $5.50Exp: 2027-10-19Common Stock (8,200 underlying)
    8,200
  • Stock Option (right to buy)

    Exercise: $5.50Exp: 2028-05-14Common Stock (3,201 underlying)
    3,201
  • Stock Option (right to buy)

    Exercise: $5.10Exp: 2030-05-14Common Stock (12,654 underlying)
    12,654
Footnotes (3)
  • [F1]The Reporting Person is the General Partner of Brightstone Venture Capital Fund, LP.
  • [F2]100% vested.
  • [F3]This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders.

Issuer

Celcuity Inc.

CIK 0001603454

Entity typeother

Related Parties

1
  • filerCIK 0001296457

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 4:19 PM ET
Size
15.7 KB